1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2011.07.022PMID 21813276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.

  2009cited by this paper
• Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.

  2009cited by this paper
• Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors.

  2007cited by this paper
• Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases?

  2006cited by this paper
• Practical methodologies for the synthesis of indoles.

  2006cited by this paper
• Selective neuronal nitric oxide synthase inhibitors.

  2005cited by this paper
• Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitors.

  2003cited by this paper
• Blocking NO synthesis: how, where and why?

  2002cited by this paper
• New ammonia equivalents for the Pd-catalyzed amination of aryl halides.

  2001cited by this paper
• ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia.

  2000cited by this paper
• Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonist.

  1999cited by this paper
• 4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors.

  1999cited by this paper
• N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.

  1998cited by this paper
• Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).

  1996cited by this paper
• Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.

  1994cited by this paper
• Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

  1987cited by this paper

• Medicinal Chemistry Insights in Neuronal Nitric Oxide Synthase Inhibitors Containing Nitrogen Heterocyclic Compounds: A Mini Review

  2024cites this paper
• Synthesis, Molecular Docking and ADME Prediction of 1H-indole/5-substituted Indole Derivatives as Potential Antioxidant and Anti-Inflammatory Agents.

  2022cites this paper
• An efficient and convenient route for the synthesis of thiophene-2-carboxamidines as potential inhibitors of nitric oxide synthase (NOS)

  2019cites this paper
• Chemistry-oriented synthesis (ChOS) and target deconvolution on neuroprotective effect of a novel scaffold, oxaza spiroquinone.

  2019cites this paper
• TLQP Peptides in Amyotrophic Lateral Sclerosis: Possible Blood Biomarkers with a Neuroprotective Role.

  2018cites this paper
• Genipin Derivatives Protect RGC-5 from Sodium Nitroprusside-Induced Nitrosative Stress

  2016cites this paper
• Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

  2014cites this paper
• The Discovery of Potentially Selective Human Neuronal Nitric Oxide Synthase (nNOS) Inhibitors: A Combination of Pharmacophore Modelling, CoMFA, Virtual Screening and Molecular Docking Studies

  2014cites this paper
• Potent and Selective Double-Headed Thiophene-2-carboximidamide Inhibitors of Neuronal Nitric Oxide Synthase for the Treatment of Melanoma

  2014cites this paper
• Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.

  2013cites this paper
• NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity.

  2012cites this paper
• First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.

  2012cites this paper
• Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).

  2012cites this paper
• Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.

  2012cites this paper
• Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.

  2012cites this paper
• 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.

  2012cites this paper
• 3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors.

  2011cites this paper
• Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain.

  2011cites this paper